Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Portola Pharmaceuticals, Inc. (Symbol: PTLA), where a total of 8,086 contracts have traded so far, representing approximately 808,600 underlying shares. That amounts to about 71.7% of PTLA's average daily trading volume over the past month of 1.1 million shares. Especially high volume was seen for the $12.50 strike call option expiring February 21, 2020, with 4,601 contracts trading so far today, representing approximately 460,100 underlying shares of PTLA. Below is a chart showing PTLA's trailing twelve month trading history, with the $12.50 strike highlighted in orange:
Regeneron Pharmaceuticals, Inc. (Symbol: REGN) options are showing a volume of 5,979 contracts thus far today. That number of contracts represents approximately 597,900 underlying shares, working out to a sizeable 68.1% of REGN's average daily trading volume over the past month, of 878,240 shares. Particularly high volume was seen for the $430 strike call option expiring April 03, 2020, with 541 contracts trading so far today, representing approximately 54,100 underlying shares of REGN. Below is a chart showing REGN's trailing twelve month trading history, with the $430 strike highlighted in orange:
And Valmont Industries Inc (Symbol: VMI) options are showing a volume of 596 contracts thus far today. That number of contracts represents approximately 59,600 underlying shares, working out to a sizeable 67.3% of VMI's average daily trading volume over the past month, of 88,600 shares. Especially high volume was seen for the $130 strike put option expiring March 20, 2020, with 58 contracts trading so far today, representing approximately 5,800 underlying shares of VMI. Below is a chart showing VMI's trailing twelve month trading history, with the $130 strike highlighted in orange:
For the various different available expirations for PTLA options, REGN options, or VMI options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
